Abstract
A lateral flow assay integrated with leukocyte isolation and on-filter cell lysis for the detection of PML–RARα nuclear fusion oncoprotein at point-of-care.
Funding Information
  • Ladies Leukemia League
  • Congressionally Directed Medical Research Programs (W81XWH-21-1-0975)
  • National Institutes of Health (R61AI174294)
  • University of Houston (GEAR Program)
  • Welch Foundation (E-1869-2024-0404)

This publication has 31 references indexed in Scilit: